Pisa syndrome associated with mirtazapine: a case report

BACKGROUND: Mirtazapine is a noradrenergic and specific serotonergic antidepressant; its pharmacological profile indicates a low risk for dopaminergic adverse effects. To date, there has been only a single case report of Pisa syndrome associated with mirtazapine. CASE PRESENTATION: The authors repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yuji, Takano, Harumasa, Yamada, Maki, Satake, Naoko, Hirabayashi, Naotsugu, Okazaki, Mitsutoshi, Nakagome, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282376/
https://www.ncbi.nlm.nih.gov/pubmed/30522528
http://dx.doi.org/10.1186/s40360-018-0272-8
Descripción
Sumario:BACKGROUND: Mirtazapine is a noradrenergic and specific serotonergic antidepressant; its pharmacological profile indicates a low risk for dopaminergic adverse effects. To date, there has been only a single case report of Pisa syndrome associated with mirtazapine. CASE PRESENTATION: The authors report a case involving a 79-year-old woman with bipolar disorder, in whom Pisa syndrome occurred after introduction of mirtazapine, and completely disappeared 3 days after suspension of the drug. CONCLUSIONS: Aspects of this particular case suggest that Pisa syndrome is a possible side effect of Mirtazapine.

Ejemplares similares